(1R,2R)-N,N’-Dimethyl-1,2-cyclohexanediamine

We are (1R,2R)-N,N’-Dimethyl-1,2-cyclohexanediamine CAS:68737-65-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(1R,2R)-N,N'-Dimethyl-1,2-cyclohexanediamine
CAS.NO:68737-65-5
Synonyms:(1R,2R)-N,N'-Dimethyl-1,2-cyclohexanediamine
(R,R)-N,N'-DIMETHYLCYCLOHEXAN-1,2-DIAMINE
trans-(1R,2R)-N,N'-dimethylcyclohexane-1,2-diamine
(1R,2R)-(-)-N,N'-Dimethylcyclohexane-1,2-diamine
trans-(1R,2R)-N,N'-bismethyl-1,2-cyclohexandiamine
trans-(1R,2R)-N,N'-bismethyl-1,2-cyclohexanediamine
 
Physical and Chemical Properties:
Density 0.9±0.1 g/cm3
Boiling Point 186.8±8.0 °C at 760 mmHg
Melting Point 39-44 °C
Molecular Formula C8H18N2
Molecular Weight 142.242
Flash Point 60.2±10.2 °C
 
Specification:
Appearance:White to light yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Oxaliplatin(CAS:61825-94-3).

(1R,2R)-N,N'-Dimethyl-1,2-cyclohexanediamine


Related News: This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.4'-carbamoyl N-Boc-2',6'-dimethyl-L-phenylalanine methyl ester At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide CAS:918504-27-5 At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.2-Chloro-3-fluorobenzaldehyde CAS:96516-31-3 At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.

Related Products
Product Name
5,6-diethyl-2,3-dihydro-1H-inden-2-amine,hydrochloride View Details
2-Ethyl-5-methylpyrazine View Details
ethyl (1S,3aR,6aS)-octahydrocyclopenta[c]pyrrole-1-carboxylate hydrochloride View Details
2-methyloxolan-3-one manufacturer n-dodecanoyl-dl-homoserine lactone manufacturer Butyl methanesulfonate manufacturer 2-chloro-6,11-dihydro-5H-benzo[b][1]benzazepine manufacturer 2,6-Diaminopyridine sulfate manufacturer